Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Artemis II astronauts will see parts of the moon no human has before. Here’s how - 2German foreign minister backs abandoning EU's unanimity principle
- 3My Excursion to Monetary Autonomy: Awesome ways to save cash
- 4Egypt seeks to calm tourist fears over fallout of Iran war
- 5Lebanese Shi’a party Amal competing, coordinating with Hezbollah, experts tell ‘Post’
- BioMarin to acquire Amicus Therapeutics for $4.8 billion in rare disease bet
- Game theory explains why reasonable parents make vaccine choices that fuel outbreaks
- From Overpowered to Coordinated: Individual Accounts of Cleaning up
- Meet the astronauts about to make history on flight around the moon
- Getting through a Lifelong Change: Individual Examples of overcoming adversity
- Germany's Pistorius: NATO protects Europe from Iranian missiles
- 4 Famous Attractions at Disneyland
- Promising Speculation Bearings for Portfolio Development in 2024
- Tech for Wellbeing: Applications and Devices for a Better You
